Hypoglycemic Agents

"Hypoglycemic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Substances which lower blood glucose levels.

Descriptor ID	D007004
MeSH Number(s)	D27.505.696.422
Concept/Terms	Hypoglycemic Agents Hypoglycemic Agents Agents, Hypoglycemic Antihyperglycemics Antihyperglycemic Agents Agents, Antihyperglycemic Hypoglycemic Drugs Drugs, Hypoglycemic Hypoglycemics Hypoglycemic Effect Hypoglycemic Effect Effect, Hypoglycemic Hypoglycemic Effects Effects, Hypoglycemic Antidiabetics Antidiabetics Antidiabetic Drugs Drugs, Antidiabetic Antidiabetic Agents Agents, Antidiabetic

Below are MeSH descriptors whose meaning is more general than "Hypoglycemic Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hypoglycemic Agents [D27.505.696.422]

Below are MeSH descriptors whose meaning is more specific than "Hypoglycemic Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hypoglycemic Agents" by people in this website by year, and whether "Hypoglycemic Agents" was a major or minor topic of these publications.

Bar chart showing 64 publications over 18 distinct years, with a maximum of 10 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	1	1	2
2001	1	1	2
2002	1	0	1
2003	0	1	1
2004	1	1	2
2005	3	2	5
2006	0	1	1
2007	2	2	4
2008	4	1	5
2009	0	5	5
2010	5	2	7
2011	5	5	10
2012	4	1	5
2013	2	1	3
2014	1	1	2
2015	2	0	2
2017	4	1	5
2018	1	1	2

Below are the most recent publications written about "Hypoglycemic Agents" by people in Profiles.

Kansagara D, Qaseem A, Wilt TJ. Guidelines on Glycemic Targets for Persons With Type 2 Diabetes. JAMA. 2018 11 13; 320(18):1937.

View in: PubMed
Mathieu C, Dandona P, Gillard P, Senior P, Hasslacher C, Araki E, Lind M, Bain SC, Jabbour S, Arya N, Hansen L, Thorén F, Langkilde AM. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial. Diabetes Care. 2018 09; 41(9):1938-1946.

View in: PubMed
Fink HA, Jutkowitz E, McCarten JR, Hemmy LS, Butler M, Davila H, Ratner E, Calvert C, Barclay TR, Brasure M, Nelson VA, Kane RL. Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review. Ann Intern Med. 2018 01 02; 168(1):39-51.

View in: PubMed
Asleh R, Briasoulis A, Schettle SD, Tchantchaleishvili V, Pereira NL, Edwards BS, Clavell AL, Maltais S, Joyce DL, Joyce LD, Daly RC, Kushwaha SS, Stulak JM. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience. Circ Heart Fail. 2017 Nov; 10(11).

View in: PubMed
Davies M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, Jabbour S, Rosenstock J. Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial. JAMA. 2017 10 17; 318(15):1460-1470.

View in: PubMed
Daniel R, Villuri S, Furlong K. Management of hyperglycemia in the neurosurgery patient. Hosp Pract (1995). 2017 Oct; 45(4):150-157.

View in: PubMed
Qaseem A, Barry MJ, Humphrey LL, Forciea MA. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. Ann Intern Med. 2017 Feb 21; 166(4):279-290.

View in: PubMed
Dardi I, Kouvatsos T, Jabbour SA. SGLT2 inhibitors. Biochem Pharmacol. 2016 Feb 01; 101:27-39.

View in: PubMed
Winters B, Plymate S, Zeliadt SB, Holt S, Zhang X, Hu E, Lin DW, Morrissey C, Wooldridge B, Gore JL, Porter MP, Wright JL. Metformin effects on biochemical recurrence and metabolic signaling in the prostate. Prostate. 2015 Nov; 75(15):1694-703.

View in: PubMed
Acharya AP, Rafi M, Woods EC, Gardner AB, Murthy N. Metabolic engineering of lactate dehydrogenase rescues mice from acidosis. Sci Rep. 2014; 4:5189.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement